Table 1

Demographic data and intraoperative characteristics

Mean or frequency
Age at surgery, years±SD (range)11.2±5.2 (0.9 to 17.9)
Follow-up time, months±SD (range)36.5±23.7 (4.2 to 92.3)
Gender (female:male)14:28
Eye (right:left)22:30
Graft size, mm±SD8.2±0.5
Recipient size, mm±SD7.8±0.6
Indications (n=eyes)
 Mucopolysaccharidosis, % (n)29.4 (15)
 Keratoconus, % (n)23.5 (12)
 Blepharokeratoconjunctivitis, % (n)17.6 (9)
 Herpes simplex keratitis, % (n)13.7 (7)
 Microbial keratitis, % (n)3.9 (2)
 Scar, % (n)7.8 (4)
 Exposure keratopathy, % (n)2.0 (1)
 Radiation keratopathy, % (n)2.0 (1)
Concurrent conditions/systemic diseases (n=patients)
 Hurler syndrome, % (n)16.7 (7)
 Other mucopolysaccharidosis types, % (n)4.8 (2)
 Patients who underwent HSCT, % (n)11.9 (5)
 Autism and/or Down syndrome, % (n)16.7 (7)
 Tourette syndrome and obsessive compulsive disorder, % (n)2.4 (1)
 Retinoblastoma, % (n)2.4 (1)
 Noonan syndrome, % (n)2.4 (1)
 Wilson-Mowat syndrome, % (n)2.4 (1)
Other procedures (n=eyes)
 Concomitant tarsorrhaphy, % (n)7.8 (4)
 Bevacizumab±FND, % (n)3.9 (2)
 Repeat DALK, % (n)5.9 (3)
  • DALK, deep anterior lamellar keratoplasty; FND, fine needle diathermy; HSCT, haematopoietic stem cell transplant.